BreakthroughsKilling diseased cells in a dish is the easy part of drug development. This guide explains the evidence ladder, why most candidates fail, and seven questions to ask before believing a breakthrough headline.
Companies + StocksMany biotech startups spend years building evidence rather than selling products. This map traces the stations most pass through, from licensing a discovery to the forks where companies partner, sell, go public or stop.
Companies + StocksBiotech companies tell two stories at once: one scientific, one financial. This educational guide, which is not investment advice, shows how to check primary sources like SEC EDGAR, ClinicalTrials.gov and FDA databases.
Companies + StocksMost medical products begin as university research, then pass through tech transfer offices, licences or spinouts, and the regulatory system. This guide maps each step and the reasons discoveries stall.
BreakthroughsHealth headlines often overstate early findings, sometimes before a journalist ever sees them. These seven questions help anyone judge a medical claim in about two minutes before sharing it.